logo

For the Inventor, By the Inventor

Kyoto, Japan

Jun Nakano

This inventor holds 13 USPTO granted patents. Top assignees: Kaken Pharmaceutical Company, Ltd., Kakenyaku Kako Co., Ltd., The University of British Columbia. Active years: 1982-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jun Nakano. Retrieved from https://idiyas.com/inventor/jun-nakano-kcj5fdkr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13

% Patents Active = 92.3

Average Co-Inventor Count = 5.4

ph-index = 4

Forward Citations = 39(Granted Patents)


Location History:

  • Moriyama, JP (1982 - 2001)
  • Kyoto, JP (1994 - 2002)

Company Filing History:

goldMedal9 out of 136 
 
Kaken Pharmaceutical Company, Ltd.
 patents
silverMedal2 out of 6 
 
Kakenyaku Kako Co., Ltd.
 patents
bronzeMedal2 out of 959 
 
The University of British Columbia
 patents

Years Active: 1982-2002

Loading Chart...
13 patents (USPTO):Explore Patents
1. 6376671 - 2-sulfamoylbenzoic acid derivatives (2002-04-23),
2. RE37449 - Process of synthesis of 3′,4′-anhydrovinblastine, vinblastine and vincristine (2001-11-13),
3. 6255321 - 2-sulfamoylbenzoic acid derivatives (2001-07-03),
4. 6048890 - Phenylamidinothiophene derivatives and anti-inflammatory agent (2000-04-11),
5. 5668147 - Quinolinecarboxylic acid derivatives and salts thereof (1997-09-16),
6. 5276041 - Oxime derivatives (1994-01-04),
7. 5158963 - 1-4-dihydropyridine derivative, process for preparing the same and (1992-10-27),
8. 5047528 - Process of synthesis of vinblastine and vincristine (1991-09-10),
9. 4731375 - Coumarin derivatives and antiallergic agents containing the same (1988-03-15),
10. 4652566 - Benzofuran derivatives, processes for preparing the same and (1987-03-24),
11. 4515977 - Process for preparing optically active (1985-05-07),
12. 4406908 - Tetrazolylcoumarin derivatives and antiallergic compositions containing (1983-09-27),
13. 4363812 - 3-(Tetrazol-5-yl), 4-methyl-8-alkoxy coumarins and anti-allergic (1982-12-14),

Title: The Innovative Journey of Inventor Jun Nakano

Introduction:

Jun Nakano, a talented inventor hailing from Kyoto, Japan, has left a significant mark in the field of pharmaceutical synthesis with his groundbreaking patented inventions. With a total of 13 patents to his name, Jun Nakano continues to push the boundaries of innovation in chemical synthesis.

Latest Patents:

Among his latest patents is the development of 2-sulfamoylbenzoic acid derivatives, along with a novel process for the synthesis of 3′,4′-anhydrovinblastine, vinblastine, and vincristine. These innovations revolutionize the synthesis of dimer alkaloid compounds, particularly those of the Catharantus (Vinca) family, showcasing his expertise in organic chemistry and pharmaceutical synthesis.

Career Highlights:

Jun Nakano's illustrious career includes notable stints at esteemed organizations such as Kaken Pharmaceutical Company, Ltd., where his inventive spirit thrived in the realm of pharmaceutical research and development. Additionally, he has also made significant contributions as a researcher at the University of British Columbia, further cementing his reputation as a pioneering inventor in the field.

Collaborations:

Throughout his career, Jun Nakano has collaborated closely with esteemed colleagues such as Yuji Suzuki and Tokiko Nishida, fostering a culture of innovation and knowledge-sharing. These collaborations have played a pivotal role in shaping his inventive journey, enabling him to harness diverse perspectives and expertise in his pioneering research endeavors.

Conclusion:

In conclusion, Jun Nakano's remarkable journey as an inventor showcases his unwavering commitment to pushing the boundaries of innovation in chemical synthesis and pharmaceutical research. His patented inventions stand as a testament to his ingenuity and dedication to advancing the field, leaving a lasting impact on the realm of organic chemistry and drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…